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Abstracts 391chimney Advanta V12 stent grafts were used (one unilateral and three
bilateral) from axillary access. In one case aorto-uniiliac Nellix was
implanted with cross-over by-pass. The decision was made during the
procedure when there was no possibility to introduce one of the stent
grafts due to tortuous and calciﬁed iliac artery. The mean length of hospital
stay was 6 days, four patients were sent to intensive care unit for one day
after the procedure. No endoleaks were noticed during the procedure and
during follow up. All prostheses remain patent. One patient was readmitted
on 17th post-operative day due to secondary aneurysm rupture. Open
conversion was performed, the Nellix stent graft was explanted and
replaced with a bifurcated graft. Further follow up was uneventful.
Conclusion: EVAS is an innovate concept in the treatment of AAA
designed to target the causes of secondary interventions such as endo-
leaks and migration. It offers an alternative for patients unsuitable for
fenestrated devices or open surgery. Results of the chimney technique,
though beyond the instruction for use for the procedure, are very
promising and in particular cases it can be an alternative to custom made
fenestrated stent grafts reducing costs and shortening the time of waiting
for interventions.
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Introduction: As the number of patients treated with endovascular
abdominal aortic repair (EVAR) is considerably growing in recent years,
related complications are observed with increasing frequency. Among
these, aortoenteric ﬁstula (AEF) is known to be a dramatic and highly lethal
event, but evidence in the literature is scant and mainly based on single
center case reports. Aim of this study is to investigate the incidence, clinical
features, therapeutic options, and outcomes of AEF developing after EVAR.
Methods: A retrospective multicenter study was conducted among
eight Italian universities and hospital centers with an abdominal aortic
endovascular program, to collect data on AEF developed after EVAR per-
formed for non-infectious disease.
Results: Among 3,932 patients who underwent EVAR between 1997 and
2013, 32 (0.8%; 27 males, mean age 72  8 years) developed an AEF.
Median time between EVAR and AEF formation was 18.5 months (inter-
quartile range, IQR: 10.5e63.5 months). Both anastomotic pseudoaneur-
ysm as the indication to EVAR, and urgent/emergent EVAR resulted
signiﬁcantly associated with AEF development (34% vs. 5%, P < 0.0001;
and 22% vs. 8%, P ¼ 0.01; respectively). Among 5 patients treated
conservatively, 2 (40%) died at 7 and 15 months respectively, while the
other 3 are alive at a median follow up of 12 months (IQR: 7e15). The
remaining 27 patients underwent AEF surgical treatment, with a peri-
operative mortality of 37% (n ¼ 10). No additional aortic related death was
recorded in operated patients at a median follow up of 28 months (IQR:
14e42).
Conclusion: Late AEF may occur in less than 1% of patients submitted to
EVAR, with an increased risk in case of emergent EVAR or performed for
pseudoaneurysm following previous aortic surgery. Both conservative and
surgical treatment of post-EVAR AEF is associated with high mortality.
However, beyond the peri-operative period, surgical correction of AEF
appears to be durable at mid-term follow up.
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rupture is unknown. The deﬁnition of common iliac aneurysm is a
maximum diameter of greater than 18e20 mm, but there is no clear
diameter deﬁnition for internal iliac aneurysms. The threshold for elective
repair in iliac aneurysms is commonly 30 mm. However, no strong scientiﬁc
data exists on the risk of rupture. The aim of the current study was to
evaluate the size of internal iliac aneurysm at the time of rupture.
Methods: This was a retrospective multicentre study including patients
with ruptured internal iliac artery aneurysm (RIIAA) from Australia, Finland,
Germany, Hungary, New Zealand, Norway and Sweden. The data on
aneurysm size at the time of rupture, information on concomitant aneu-
rysms in aorta, ipsilateral common iliac artery as well as contralateral iliac
arteries, treatment of the RIIAA as well as outcome were collected from CT-
images and patients’ case records.
Results: In total 59 RIIAA patients were treated during 2004e2014.
Median diameter at the time of rupture was 67.5 mm (IQR 52e85 mm,
range 25 e116 mm). In one patient (1.8%) the maximum diameter was less
than 3 cm, in 3 patients (5.5%) less than 4 cm. Mean age at the time of
rupture was 77 years. 86% of patients were men. 57% had bilateral IIAA,
64% also had an aneurysmal common iliac artery and 44% also had AAA.
38% had involvement of internal and common iliac arteries and the aorta.
29% had an isolated internal iliac aneurysm. Repair by either open pro-
cedure (n ¼ 42, 71%), endovascular procedure (n ¼ 12, 20%) or hybrid
procedure (n ¼ 5, 8.5%) was performed on all patients. 30 day mortality
was 19%; 8.3% after endovascular treatment, 21% after open surgery and
20% after a hybrid procedure.
Conclusion: Internal iliac artery aneurysm ruptures are rare. As with
RAAA most of the patients are male. Compared to operative RAAA
mortality, RIIAA mortality seems to be somewhat lower with less than 20
% mortality at 30 days. The median size of the aneurysm at the time of
rupture was 67 mm, compared to 76 mm in abdominal aortic aneurysms.
Only one patient had a rupture at a diameter of less than 3 cm, which
suggests that the threshold for elective treatment might be quite safely
increased to 4 cm.
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Introduction: With the advancement of endovascular techniques (EVAR)
for abdominal aortic aneurysm repair (AAA), the number of patients
treated for juxta- and suprarenal aneurysms with EVAR is increasing. During
the adoption of new treatment strategies, it is important to track perfor-
mances and compare results to conventional treatment. The purpose of
this study was, therefore, to examine perioperative outcomes in patients
undergoing endovascular juxta- and suprarenal AAA repair and compare
those results to conventional open repair.
Methods: We identiﬁed all patients undergoing non-emergent EVAR or
open repair for juxta- and suprarenal AAA between January 2003 and
December 2014 in the Targeted Vascular data set from the American
College of Surgeons National Surgical Quality Improvement Program.
Comparative analyses included patient and intraoperative characteristics,
in addition to 30-day postoperative outcomes. Independent risk factors for
morbidity and mortality were established using multivariable logistic
regression analysis.
Results: A total of 907 patients were included, with 411 (45%) un-
dergoing EVAR, and 496 (55%) undergoing open repair. Perioperative
mortality following EVAR was 2.2% vs. 4.6% after open repair
(P ¼ .047). Postoperative deterioration of renal function was less
common among patients undergoing EVAR (2.2% vs. 8.7%, P < .001), as
well as the need for dialysis (1.2% and 5.2%, P ¼ .001). Other differ-
ences in perioperative morbidity after EVAR and open repair, respec-
tively, included the occurrence of ischemic colitis (1.0% vs. 5.0%,
P < .001), myocardial infarction (0.7% vs. 3.8%, P ¼ .002), wound
dehiscence (0.2% vs. 2.6%, P ¼ .005), pneumonia (1.2% vs. 7.9%,
P < .001), prolonged ventilator dependence (1.9% vs. 13.5%, P < .001)
